zur Startseite
News/Publications
 

Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Kastritis E, Leblond V, Dimopoulos MA, Kimby E, Staber P, Kersten MJ, Tedeschi A, Buske C; ESMO Guidelines Committee.
read more ›
 

Clinical Intergroup

Clinical Intergroup

 

The ECWM is based on a clinical intergroup connecting all major clinical national study groups such as:

  • BNLI
  • Czech Myeloma Group
  • FIL Italian Intergroup
  • FCGCLLWM Group
  • GLA/OSHO
  • Greek Myeloma Study Group 
  • HOVON 
  • Nordic Lymphoma Group
  • Portuguese Lymphoma Study Group
  • Spanish Study Group 

The ECWM is associated with the Australasian Leukaemia & Lymphoma Goup (ALLG). This clinical intergroup forms a unique platform for setting up large clinical and innovative trials in a rare disease such as WM.

 

Currently several clinical trials are initiated which offer patients with WM novel therapeutic approaches in the setting of well controlled clinical trials.